Correvio Pharma Corp Receivables Turnover Ratio (CORV), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Correvio Pharma Corp   (CORV)
 

Correvio Pharma Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Correvio Pharma Corp 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2019 to a ratio of 3.62, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2019. Average receivable collection period, for the Correvio Pharma in Dec 31 2019 quarter, has decreased to 101 days, compared to 115 days, in the 0 quarter.

If we take a look into Healthcare sector 521 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2019 from 0 to 3839.

What is Receivable Turnover Ratio?
What is Correvio Pharma Corp Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CORV Receivables Turnover Ratio (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Receivable Change -9.8 % 55.21 % 55.21 % 55.21 % -18.4 %
Y / Y Revenue Change 13.81 % - - - 19.44 %
Receivable Turnover Ratio (TTM) 3.62 3.18 3.61 4.17 4.93
CORV's Total Ranking # 3839 # 0 # 3838 # 0 # 3838
Accounts Receivable average collection period days 101 115 101 88 74
Seq. Receivable Change -99.23 % 0 % 0 % 11651.96 % -98.68 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 214
Healthcare Sector # 522
Overall Market # 3839

Receivable Turnover Ratio Statistics
High Average Low
3.76 3.36 2.72
(Dec 31 2017)   (Dec 31 2019)





CORV Company Profile • Back to CORV Efficiency Comparisons • Compare CORV Receivables Turnover Ratio to its Competitors

Financial Statements
Correvio Pharma 's Accounts Receivable $ 0 Millions Visit CORV's Balance sheet
Correvio Pharma 's Sales TTM $ 33 Millions Visit CORV's Income Statement
Sources of CORV's Revenues Visit CORV's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CORV's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CORV's Growth Rates CORV's Roa CORV's Inventory Turnover Ratio CORV's Dividend Comparisons
CORV's Profitability Ratios CORV's Roi CORV's Asset Turnover Ratio CORV's Dividend Growth
CORV's Valuation Ratios CORV's Roe CORV's Financial Strength Ratios CORV's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Receivable at quarter ending Dec 31 2019
Theravance Biopharma inc   944.23 $ 73.414  Millions$ 0.078  Millions
Jrsis Health Care Corp  826.57 $ 31.463  Millions$ 0.038  Millions
Arena Pharmaceuticals Inc   390.67 $ 806.431  Millions$ 2.064  Millions
Icon Plc  380.19 $ 2,805.839  Millions$ 7.380  Millions
Correvio Pharma Corp   354.72 $ 32.634  Millions$ 0.092  Millions
Waters Corporation  289.05 $ 2,406.596  Millions$ 8.326  Millions
Exicure Inc   272.84 $ 1.296  Millions$ 0.005  Millions
Logicmark Inc  251.46 $ 17.137  Millions$ 0.068  Millions
Decoy Therapeutics Inc   236.69 $ 2.210  Millions$ 0.009  Millions
Vystar Corporation  229.76 $ 13.686  Millions$ 0.060  Millions
H cyte Inc  222.72 $ 8.347  Millions$ 0.037  Millions
Athersys Inc  183.19 $ 5.633  Millions$ 0.031  Millions
Optinose Inc   168.73 $ 34.631  Millions$ 0.205  Millions
Reliv International Inc  167.39 $ 35.055  Millions$ 0.209  Millions
Mersana Therapeutics inc   159.86 $ 42.123  Millions$ 0.264  Millions
Siga Technologies Inc  149.34 $ 487.358  Millions$ 3.263  Millions
Qiagen N v   125.99 $ 1,526.424  Millions$ 12.115  Millions
Lifevantage Corp  112.42 $ 229.652  Millions$ 2.043  Millions
Editas Medicine Inc   110.83 $ 20.531  Millions$ 0.185  Millions
Fate Therapeutics Inc   85.44 $ 10.680  Millions$ 0.125  Millions
U s Stem Cell Inc   84.84 $ 3.072  Millions$ 0.036  Millions
Lifemd Inc   71.33 $ 12.469  Millions$ 0.175  Millions

Date modified: 2026-09-08T15:09:54+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.